Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CGRP
Marketing
Lilly's Emgality fails to top Pfizer's Nurtec in migraine trial
Eli Lilly's Emgality didn’t outdo Pfizer’s Nurtec in the prevention of migraines in a head-to-head trial.
Angus Liu
Jun 20, 2023 3:24pm
AbbVie's Qulipta gains approval to prevent chronic migraines
Apr 18, 2023 3:20pm
Teva notched a win in its migraine patent feud with Eli Lilly
Oct 5, 2022 10:35am
Daiichi-Seagen, Roche-Jemincare, AbbVie-I-Mab—Fierce Pharma Asia
Aug 19, 2022 9:35am
Setback at Lundbeck: CGRP migraine drug Vyepti hits trial snag
Aug 18, 2022 12:01pm
More discussion needed on migraine, mental health link: survey
Aug 1, 2022 7:25am
